{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:50Z","timestamp":1747181210874,"version":"3.40.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,9]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Splenic marginal zone lymphoma (SMZL), an indolent small B-cell lymphoma, is uncommon, and part of the patients exist plasmocytic differentiation and secrete monoclonal paraproteins including IgM predominantly. SMZL with monoclonal IgG is rarer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We report a case of SMZL (49-year-old, male) with monoclonal IgG, MYD88L265P mutation and hepatitis B virus infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The patient was presented to our hospital with aggravating complaints of dizziness, fatigue, postprandial abdominal distension, and night sweats. The diagnosis was confirmed by clinical manifestations, immunophenotype, bone marrow pathology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient received rituximab-based chemotherapy and sequential ibrutinib in combination with entecavir.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After 1 year of follow-up, his blood routine examination had returned to normal with normal level of albumin and significantly lower globulin than before, and the spleen was of normal size.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We conclude that rituximab-based chemotherapy is the main treatment option for the patients with SMZL, and Bruton\u2019s tyrosine kinase inhibitor has also shown beneficial efficacy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037158","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:18Z","timestamp":1707509178000},"page":"e37158","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Splenic marginal zone lymphoma with monoclonal IgG: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Xupai","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihui","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoping","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0626-9559","authenticated-orcid":false,"given":"Fangyi","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/aol-20-28","article-title":"Epidemiology of marginal zone lymphoma.","volume":"5","author":"Cerhan","year":"2021","journal-title":"Ann Lymphoma"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pathol.2019.08.012","article-title":"Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches.","volume":"52","author":"Nakamura","year":"2020","journal-title":"Pathology"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1182\/blood-2015-11-624312","article-title":"Splenic marginal zone lymphoma: from genetics to management.","volume":"127","author":"Arcaini","year":"2016","journal-title":"Blood"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use.","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdn563","article-title":"Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients.","volume":"20","author":"Boveri","year":"2009","journal-title":"Ann Oncol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","article-title":"MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.","volume":"39","author":"Martinez-Lopez","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3816\/CLML.2011.n.019","article-title":"CD138 expression helps distinguishing Waldenstrom\u2019s macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL).","volume":"11","author":"Kyrtsonis","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/ijlh.13467","article-title":"The relative expression levels of CD148 and CD180 on clonal B cells and CD148\/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltrating blood and bone marrow \u2013 results from a single centre pilot study.","volume":"43","author":"Gautam","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing.","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3389\/fonc.2020.00640","article-title":"Identification of a splenic marginal zone lymphoma signature: preliminary findings with diagnostic potential.","volume":"10","author":"Robinson","year":"2020","journal-title":"Front Oncol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3816\/CLML.2011.n.020","article-title":"Distinctive clinical and histological features of Waldenstrom\u2019s macroglobulinemia and splenic marginal zone lymphoma.","volume":"11","author":"Arcaini","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/IR:36:1:27","article-title":"From B cell to plasma cell: regulation of V(D)J recombination and antibody secretion.","volume":"36","author":"Borghesi","year":"2006","journal-title":"Immunol Res"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia\/lymphoplasmacytic lymphomas.","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood-2018-02-833608","article-title":"Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.","volume":"132","author":"Kalpadakis","year":"2018","journal-title":"Blood"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"98757","DOI":"10.18632\/oncotarget.21931","article-title":"Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region.","volume":"8","author":"Yi","year":"2017","journal-title":"Oncotarget"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:01:17Z","timestamp":1746316877000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037158","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,2,9]]}}}